The global orthopedic biomaterial market is anticipated to grow at a CAGR of 7.2% during the forecast period (2023-2030). The development of new orthopedic biomaterial across the globe to cater the growing demand for orthopedic biomaterials is a key factor driving the growth of the global orthopedic biomaterial market. For instance, in December 2022, Stryker Corp. has launched Citrefix, a suture anchor system for foot and ankle surgical procedures. The new system uses Citregen, a bioresorbable material designed to mimic the chemistry and structure of native bone. These unique chemical and mechanical properties are designed to help grafted tissue heal and healthy bone to grow when used in orthopaedic surgical applications.
Browse the full report description of “Orthopedic biomaterial Market Size, Share & Trends Analysis Report, By Material Type (Polymers, Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Metal, Others), By Application (Orthobiologics, Joint Replacement/Reconstruction, Viscosupplementation, Orthopedic Implants, Others) Forecast Period (2022-2030)” at https://www.omrglobal.com/industry-reports/orthopedic-biomaterial-market
Further, in March 2021, OSSIO, Inc., an orthopedic fixation technology company has launched OSSIOfiber Compression Screws for maintenance of alignment and fixation of bone fractures, comminuted fractures, fragments, osteotomies, arthrodesis and bone grafts of the upper extremity, fibula, knee, ankle and foot in the presence of appropriate brace and/or immobilization. The OSSIOfiber Compression Screw portfolio received 510(k) market clearance from the US Food and Drug Administration (FDA) in 2020 and the initial product offering is applicable for use in the treatment of multiple lower and upper extremity injuries.
The bio-integrative implant delivers a combination of superior mechanical performance with better bone healing versus conventional metal screws and is the only compression screw on the market that combines the necessary strength for secure bone fixation with the ability to fully integrate into the surrounding anatomy without adverse foreign body reactions or stress shielding, while avoiding implant related complications and secondary hardware removal surgeries often associated with permanent metal implants.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Material Type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Koninklijke DSM N.V, Zimmer Biomet Ltd., Stryker Corp., Invibio Ltd. and Evonik Industries AG among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Orthopedic Biomaterial Market Report Segment
By Material Type
By Application
Global Orthopedic Biomaterial Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/orthopedic-biomaterial-market